)
CareDx (CDNA) investor relations material
CareDx Wells Fargo 20th Annual Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic opportunities and market outlook
Early-stage adoption in organ transplant molecular monitoring presents significant growth potential, with molecular testing becoming a standard of care and continued market penetration expected.
The company is recognized as an innovator, with a 25-year mission focused on improving patient outcomes in transplantation.
Solutions-based selling and a broad portfolio, including software, IVD kits, and molecular monitoring, drive adoption and operational efficiency at transplant centers.
Digital solutions and SaaS transformation are key differentiators, supporting two-thirds of U.S. transplant centers and enhancing administrative efficiency.
Ongoing investments in commercial teams and technology infrastructure aim to accelerate growth and market reach.
Operational performance and growth drivers
Q2 saw strong test volume growth, with kidney testing up nearly 20% and 60 centers adopting surveillance protocols.
Surveillance testing adoption is expanding, with over 200 kidney transplant programs in the U.S. and significant room for further protocol implementation.
Epic system integration is expected to streamline operations, targeting 10% of volume by year-end and aiming for 50% by next year, despite administrative hurdles.
Revenue cycle management overhaul has improved workflows, reduced zero pays, and is projected to increase ASP to $1,400 in the first half of 2025.
Digital and patient solutions segment, about 15% of revenue, has grown at a 20–30% CAGR, with bundled solutions driving higher test utilization and revenue.
Policy, payer coverage, and clinical evidence
Recent policy changes affirmed coverage for kidney surveillance testing, a major advocacy win, though draft LCDs propose frequency caps and single-test reimbursement per service date.
The company submitted detailed feedback advocating for clinician-driven testing frequency and dual-test coverage for heart transplants.
The KOR study demonstrated surveillance testing detects rejection up to three months earlier than clinical symptoms, supporting higher test frequency and payer adoption.
Expansion of in-network commercial payer contracts, aided by new CPT codes, is expected to improve payment speed, predictability, and utilization.
High clinical evidence publication rate supports medical necessity and drives broader payer acceptance.
Next CareDx earnings date
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)